Amy Ewald
University of South Florida(US)Retina Vitreous Associates of Florida(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Pharmacological Receptor Mechanisms and Effects, Retinal Diseases and Treatments
Most-Cited Works
- → Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues(2014)115 cited
- → Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism(2014)103 cited
- → Salvinorin A Analogs and Other Kappa-Opioid Receptor Compounds as Treatments for Cocaine Abuse(2014)70 cited
- → Pharmacology and anti‐addiction effects of the novel κ opioid receptor agonistMesylSalB, a potent and long‐acting analogue of salvinorinA(2014)64 cited
- → The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats(2013)33 cited
- → Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)(2022)33 cited
- → The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects(2017)31 cited
- → The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors(2023)9 cited
- → Screen Failures in Clinical Trials in Retina(2024)3 cited
- → Investigating the anti-cocaine effects of novel kappa opioid receptor agonists: Behavioural and cellular actions of Salvinorin A analogues(2016)2 cited